Huo TI - Search Results

1

Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma.

Huang YH, Wu JC, Lui WY, Chau GY, Tsay SH, Chiang JH, King KL, Huo TI, Chang FY, Lee SD. Huang YH, et al. Among authors: huo ti. World J Surg. 2000 May;24(5):551-5. doi: 10.1007/s002689910090. World J Surg. 2000. PMID: 10787075 Clinical Trial.

2

Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study.

Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Scand J Gastroenterol. 2003 Jul;38(7):770-8. doi: 10.1080/00365520310003048. Scand J Gastroenterol. 2003. PMID: 12889565 Clinical Trial.

3

Reliability of contemporary radiology to measure tumour size of hepatocellular carcinoma in patients undergoing resection: limitations and clinical implications.

Huo TI, Wu JC, Lui WY, Lee RC, Loong CC, Huang YH, Tsay SH, Chang FY, Lee SD. Huo TI, et al. Scand J Gastroenterol. 2004 Jan;39(1):46-52. doi: 10.1080/00365520310007242. Scand J Gastroenterol. 2004. PMID: 14992561 Clinical Trial.

4

Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection.

Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Scand J Gastroenterol. 2004 Feb;39(2):168-73. doi: 10.1080/00365520310008269. Scand J Gastroenterol. 2004. PMID: 15000280

5

Comparison of clinico-pathological features in hepatitis B virus-associated hepatocellular carcinoma with or without hepatitis D virus superinfection.

Huo TI, Wu JC, Lai CR, Lu CL, Sheng WY, Lee SD. Huo TI, et al. J Hepatol. 1996 Oct;25(4):439-44. doi: 10.1016/s0168-8278(96)80202-9. J Hepatol. 1996. PMID: 8912142

6

Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D.

Wu JC, Choo KB, Chen CM, Chen TZ, Huo TI, Lee SD. Wu JC, et al. Among authors: huo ti. Lancet. 1995 Oct 7;346(8980):939-41. doi: 10.1016/s0140-6736(95)91558-3. Lancet. 1995. PMID: 7564729

7

Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors.

Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD. Huo TI, et al. J Gastroenterol Hepatol. 1997 Nov;12(11):747-51. doi: 10.1111/j.1440-1746.1997.tb00364.x. J Gastroenterol Hepatol. 1997. PMID: 9430041

8

Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.

Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, Chang FY, Lee SD. Huo TI, et al. Hepatology. 1998 Jul;28(1):231-6. doi: 10.1002/hep.510280130. Hepatology. 1998. PMID: 9657117

9

Diagnostic value of anti-hepatitis D virus (HDV) antibodies revisited: a study of total and IgM anti-HDV compared with detection of HDV-RNA by polymerase chain reaction.

Huang YH, Wu JC, Sheng WY, Huo TI, Chang FY, Lee SD. Huang YH, et al. Among authors: huo ti. J Gastroenterol Hepatol. 1998 Jan;13(1):57-61. doi: 10.1111/j.1440-1746.1998.tb00546.x. J Gastroenterol Hepatol. 1998. PMID: 9737573

10

Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.

Huo TI, Yang WC, Wu JC, King KL, Loong CC, Lin CY, Lui WY, Chang FY, Lee SD. Huo TI, et al. Zhonghua Yi Xue Za Zhi (Taipei). 2000 Feb;63(2):93-100. Zhonghua Yi Xue Za Zhi (Taipei). 2000. PMID: 10677918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters